Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Agents or interventions that increase the expression of the CHM gene, which encodes Rab escort protein-1 (REP-1). REP-1 is essential for intracellular trafficking by facilitating the prenylation and membrane targeting of Rab GTPase proteins. Increasing CHM expression is a therapeutic strategy for choroideremia, an X-linked retinal degenerative disease caused by mutations in the CHM gene. Approaches include inhibiting nonsense-mediated decay (NMD) of mutant CHM transcripts and gene augmentation therapy to deliver functional copies of CHM.
Inhibition of nonsense-mediated decay, exogenous gene delivery
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rab escort protein-1 expression stimulant.